Antitumor activity of the WEE1 inhibitor AZD1775 as a monotherapy and in combination with the PARP inhibitor olaparib in patient-derived explant (PDX) models
O'Connor, M.J, Odedra, R, Palakurthi, S, Hughes, A, Lai, Z, Kirschmeier, P, Zeng, Q, Zhou, S, Dharma, S, Ivanova, E, Wang, A, Pierce, A.J, Yates, J, Powell, S, Dougherty, B, Barrett, J.C, English, J, Jewsbury, P, Matulonis, U.A, Liu, J.F
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
436 - Antitumor activity of the WEE1 inhibitor AZD1775 as a monotherapy and in combination with the PARP inhibitor olaparib in patient-derived explant (PDX) models
O'Connor, M.J., Odedra, R., Palakurthi, S., Hughes, A., Lai, Z., Kirschmeier, P., Zeng, Q., Zhou, S., Dharma, S., Ivanova, E., Wang, A., Pierce, A.J., Yates, J., Powell, S., Dougherty, B., Barrett, J.C., English, J., Jewsbury, P., Matulonis, U.A., Liu, J.F.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article